EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differences in amyloid PET positivity based on ethnoracial group and social determinants of health: The new IDEAS study

Corey J Bolton, Peggye Dilworth-Anderson, Jon Steingrimsson, Maryanne Thangarajah, Lucy Hanna, Constantine Gatsonis, Charles Windon, Maria C Carrillo, Emily Glavin, Ilana Gareen, Margo B Heston, Bruce E Hillner und 8 weitere

Alzheimer's & Dementia · 2026

DOI: 10.1002/alz.71406 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Corey J Bolton und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Geriatric Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Amyloid, Cognitive Dysfunction, Positron-Emission Tomography, Social Determinants of Health. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION This study leverages a large, diverse cohort to characterize ethnoracial differences in amyloid positron emission tomography (PET) positivity and identify social determinants of health (SDOHs) contributing to these differences. METHODS We assessed differences in amyloid PET positivity by ethnoracial group (Black, Latinx, or all other races/ethnicities [AORE]) among Medicare beneficiaries with cognitive impairment. Secondary analyses associated various SDOHs with amyloid PET positivity. RESULTS Among 5757 participants (21.7% Black, 20.3% Latinx, 58.1% AORE), we found lower odds of amyloid positivity in Black (odds ratio [OR]: 0.72, 95% confidence interval [CI]: 0.62–0.83) and Latinx (OR: 0.78, 95% CI: 0.67–0.91) compared to AORE. Individuals in the comfortable (OR: 1.22, 95% CI: 1.05–1.42) and distressed (OR: 1.40, 95% CI: 1.08–1.82) Area Deprivation Index (ADI) groups had greater odds of amyloid positivity than individuals in the prosperous group. DISCUSSION Amyloid PET positivity rates were lower among Black and Latinx individuals and higher among individuals in more deprived ADI categories. This has potential implications for anti‐amyloid therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmyloidCognitive DysfunctionPositron-Emission TomographySocial Determinants of HealthAgedAged, 80 and overFemaleHumansMaleBlack or African AmericanHispanic or LatinoMedicareSocioeconomic Disparities in HealthUnited States

Stichwörter der Autor:innen

Alzheimer'samyloid PETdisparitiesethnoracial differences

Substanzen

Amyloid

Autor:innen und Institutionen

  • Department of Medicine, Division of Geriatric Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Department of Biostatistics, Brown University, Providence, Rhode Island, USA.
  • Center for Biostatistics and Health Data Science, Brown University School of Public Health, Providence, Rhode Island, USA.
  • Department of Neurology, Edward and Pearl Fein Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA.

ORCID-Profile: Consuelo H Wilkins

Förderung

  • NCATS NIH HHS
  • NIH HHS
  • NIA NIH HHS
  • Eli Lilly and Company
  • Life Molecular Imaging
  • Alzheimer's Association
  • American College of Radiology
  • General Electric Healthcare

Zitieren

APA

Bolton, C. J., Dilworth-Anderson, P., Steingrimsson, J., Thangarajah, M., Hanna, L., Gatsonis, C., Windon, C., Carrillo, M. C., Glavin, E., Gareen, I., Heston, M. B., Hillner, B. E., March, A., Rissman, R. A., Siegel, B. A., Smith, K., Whitmer, R. A., Weber, C. J., Rabinovici, G. D., & Wilkins, C. H. (2026). Differences in amyloid PET positivity based on ethnoracial group and social determinants of health: The new IDEAS study. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71406

Vancouver

Bolton CJ, Dilworth-Anderson P, Steingrimsson J, Thangarajah M, Hanna L, Gatsonis C, et al. Differences in amyloid PET positivity based on ethnoracial group and social determinants of health: The new IDEAS study. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71406

BibTeX
@article{Bolton2026,
  author = {Bolton, Corey J and Dilworth-Anderson, Peggye and Steingrimsson, Jon and Thangarajah, Maryanne and Hanna, Lucy and Gatsonis, Constantine and Windon, Charles and Carrillo, Maria C and Glavin, Emily and Gareen, Ilana and Heston, Margo B and Hillner, Bruce E and March, Andrew and Rissman, Robert A and Siegel, Barry A and Smith, Karen and Whitmer, Rachel A and Weber, Christopher J and Rabinovici, Gil D and Wilkins, Consuelo H},
  title = {Differences in amyloid PET positivity based on ethnoracial group and social determinants of health: The new IDEAS study},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  doi = {10.1002/alz.71406}
}
Kostenlos starten →